FDA Approved: NAPROXEN — Supplemental Application (Zameer Pharmaceuticals LLC)

View source ↗

Summary

The FDA has approved a supplemental application for naproxen filed by Zameer Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dysmenorrhea
• Gout
• Osteoarthritis
• Pain
• Rheumatoid Arthritis

Drugs mentioned

• Naproxen (Naproxen)

Snippet

SUPPL AP for NAPROXEN (NAPROXEN)